報價延遲最少15分鐘:2024/05/20 16:38 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
174.39 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
5.19/6.13
|
|
企業價值
86.17B
|
| 資產負債 |
|
每股賬面淨值
11.08
|
| 現金流量 |
|
現金流量率
0.03
|
| 損益表 |
|
收益
8.54B
|
|
每股收益
18.35
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2024/05/20 16:38 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit. |